American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

The push for an independent cardiology board continues
Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.
What happened to cardiology's private practices?
Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.
Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.
Why the business side of cardiology was a key focus at ACC.24
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
The growing shortage or general cardiologists and recruiting crisis in rural America
There is a rapidly growing shortage in general cardiologists and for positions in rural areas, numerous healthcare system recruiters set up at the ACC reported.

Edward Fry, MD, is the 2022-23 ACC president.

Q&A: New ACC President Edward Fry discusses the past, present and future of cardiology

Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more.

April 18, 2022

In a late-breaking long-term analysis presented at ACC 2022, the Medtronic CoreValve TAVR valve outperformed the surgical aortic valve replacement (SAVR) in terms of durability.

VIDEO: TAVR durability outperforms surgical valves

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

April 13, 2022

An implantable cardioverter defibrillator (ICD) and its associated leads viewed on a X-ray. Old leads are often abandon in veins and new ones added, but a new study of 1 million patients at ACC22 showed there is higher mortality if a device becomes infected and the leads are left behind. Image from RSNA.

VIDEO: Lowering mortality rates from infected EP implantable cardiac devices

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.

April 11, 2022

A late-breaking study at ACC.22 showed differences in COVID-positive heart attack patients between 2020 and 2021. #ACC22 #ACC2022

VIDEO: Vaccines boosted survival among STEMI heart attack patients with COVID-19

Santiago Garcia, MD, lead author of the study and director of the structural heart program at The Christ Hospital in Cincinnati, Ohio, presented new data from the North American COVID-19 STEMI (NACMI) registry at ACC.22. Severity of heart attacks were reduced in vaccinated patients, with zero deaths in vaccinated patients in 2021.

April 8, 2022

Ami Bhatt, MD, the American College of Cardiology (ACC) Chief Innovation Officer, and an Adult Congenital Heart Disease cardiologist at Mass General Hospital (MGH). She is viewed one of the national experts on telecardiology, having been the former director of telecardiology at Mass General during 2020-2021.

VIDEO: American College of Cardiology working to propel cardiovascular innovation

Ami Bhatt, MD, explained how the ACC is working to advance new technologies that can improve patient care.

March 18, 2022

Around the web

Cardiovascular Business

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.

Cardiovascular Business

The push for an independent cardiology board continues

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

AI in Healthcare

Biden Administration itemizes AI accomplishments to date

Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.